TERN — Terns Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual balance sheet for Terns Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	74.9	166	283	263	358
Net Total Receivables	12.7	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	90.9	167	285	267	362
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.18	1.05	1.8	1.03	1.47
Other Long Term Assets
Total Assets	92.3	168	287	269	364
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	22.8	6.82	8.47	11.9	15.7
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	23.7	7.77	10.1	13.2	18.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	68.6	160	277	255	346
Total Liabilities & Shareholders' Equity	92.3	168	287	269	364
Total Common Shares Outstanding